Cohance Lifesciences Limited
COHANCE
株式のランク
#6496
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
株価
$4.80
時価総額
$1.84B
変化（1日）
-5.65%
変化（1年）
-59.50%
国
IN
取引 Cohance Lifesciences Limited (COHANCE)
カテゴリー
Healthcare
Cohance Lifesciences Limited（COHANCE）の株価履歴
終値の最高値: $12.03 （2025-06-01）
終値の最安値: $1.65 （2020-03-01）
終値の最安値: $1.65 （2020-03-01）
Cohance Lifesciences Limited の株価履歴（2020 ～ 2026）
年間株価パフォーマンス
| 年 | パフォーマンス |
|---|---|
| 2025 | -17.24% |
| 2024 | 75.72% |
| 2023 | 43.40% |
| 2022 | -12.41% |
| 2021 | 15.53% |
| 2020 | 0.00% |
類似企業または競合の株価
| 企業 | 株価 | 変化率 1年% | 国 |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
